Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2016 Jul;25(7):1029-36.
doi: 10.1158/1055-9965.EPI-16-0133.

Anticipating the "Silver Tsunami": Prevalence Trajectories and Comorbidity Burden among Older Cancer Survivors in the United States

Shirley M Bluethmann  1 , Angela B Mariotto  2 , Julia H Rowland  3
Affiliations
Editorial

Anticipating the "Silver Tsunami": Prevalence Trajectories and Comorbidity Burden among Older Cancer Survivors in the United States

Shirley M Bluethmann et al. Cancer Epidemiol Biomarkers Prev. 2016 Jul.

Abstract

Background: Cancer survivors are a growing population, due in large part to the aging of the baby boomer generation and the related "silver tsunami" facing the U.S. health care system. Understanding the impact of a graying nation on cancer prevalence and comorbidity burden is critical in informing efforts to design and implement quality cancer care for this population.

Methods: Incidence and survival data from 1975 to 2011 were obtained from the Surveillance, Epidemiology, and End Results (SEER) Program to estimate current cancer prevalence. SEER-Medicare claims data were used to estimate comorbidity burden. Prevalence projections were made using U.S. Census Bureau data and the Prevalence Incidence Approach Model, assuming constant future incidence and survival trends but dynamic projections of the U.S.

Results: In 2016, there were an estimated 15.5 million cancer survivors living in the United States, 62% of whom were 65 years or older. The prevalent population is projected to grow to 26.1 million by 2040, and include 73% of survivors who are 65 years and older. Comorbidity burden was highest in the oldest survivors (those ≥85 years) and worst among lung cancer survivors.

Conclusions: Older adults, who often present with complex health needs, now constitute the majority of cancer survivors and will continue to dominate the survivor population over the next 24 years.

Impact: The oldest adults (i.e., those >75 years) should be priority populations in a pressing cancer control and prevention research agenda that includes expanding criteria for clinical trials to recruit more elderly participants and developing relevant supportive care interventions. Cancer Epidemiol Biomarkers Prev; 25(7); 1029-36. ©2016 AACR.

PubMed Disclaimer

Conflict of interest statement

Disclosure of Potential Conflicts of Interest:

The authors confirm there are no potential conflicts of interest.

Figures

Figure 1
Figure 1
Estimated cancer prevalence by age in the US population from 1975 (216 M) to 2040 (380 M)
Figure 2
Figure 2
Percent of cancer survivors in the US population (324 M) by gender and age, 2016
See this image and copyright information in PMC

References

    1. Parry C, Kent EE, Mariotto AB, Alfano CM, Rowland JH. Cancer survivors: A booming population. Cancer Epidemiol Biomarkers Prev. 2011 Oct;20:1996–2005. - PMC - PubMed
    1. Frey WH. Baby boomers and the new demographics of america's seniors. Generations. 2010;34:28–37.
    1. de Moor JS, Mariotto AB, Parry C, Alfano CM, Padgett L, Kent EE, et al. Cancer survivors in the united states: Prevalence across the survivorship trajectory and implications for care. Cancer Epidemiol Biomarkers Prev. 2013 Apr;22:561–570. - PMC - PubMed
    1. Levit L, Balogh E, Nass S, Ganz PA. Delivering high-quality cancer care: Charting a new course for a system in crisis. Washington, DC: Institute of Medicine; 2013. - PubMed
    1. Rowland JH, Bellizzi KM. Cancer survivorship issues: Life after treatment and implications for an aging population. Journal of Clinical Oncology. 2014 Aug 20;32:2662–2668. - PMC - PubMed

Publication types